Ledger.Open graph →

SEC Form D · Amendment · filed May 6, 2025

CND Life Sciences, Inc

Offering

$9.0M

Sold

$8.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SCOTTSDALE, AZ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Peter J. Harris · Brookline, MAExec · Director Enrique J. Carrazana · Coral Gables, FLDirector Jack J. Seaver · New York, NYDirector Christopher J. Gibbons · Brookline, MADirector Todd J. Levine · Paradise Valley, AZExec · Director Richard J. Morello · Atlanta, GAExec · Director Haakon Overli · London, United KingdomExec · Director Jack J. Seaver · New York, NYDirector Colby Fryar · Phoenix, AZExec · Director Robert Hartog · Denver, CODirector GCR CJ Master LLC · Sacramento, CADirector Alex Appleton · London, United KingdomExec · Director Todd Sachse · Detroit, MIExec · Director Harvey Koo · San Francisco, CADirector Merredith Treaster · San Francisco, CAExec · Director Alexander M. Liang, M.D · Dallas, TXDirector Limited Liability Company Sjs GP · New York, NYExec · Director Jacob Hall · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗